Skip to content
value.today

Oncosynergy, Inc.

Total raised
$33 M
4 rounds on record
Latest round
$7 M
May 2026
First round on record
Apr 2018
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Oncosynergy, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2026$7 MNo. 4$2 to $10 million

Oncosynergy, Inc.: Raise no. 4, May 2026

Investors in this round

5 investors had bought by the notice of May 26, 2026: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $8 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anne-Marie Suh Carbonell · Executive Officer, Director
  • Allen Salmasi · Director
  • Hen Suh Park · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amounts include conversion of outstanding convertible securities.”

Signed by Anne-Marie Carbonell, President. Source: SEC Form D, newest notice filed May 26, 2026. Read the notice at the SEC.

equitySEC
Nov 2020$3 MNo. 3$2 to $10 million

Oncosynergy, Inc.: Raise no. 3, Nov 2020

Investors in this round

4 investors had bought by the notice of May 16, 2022: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $7 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$46,587
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anne-Marie Suh Carbonell · Executive Officer, Director
  • Allen Salmasi · Director
  • Colin Suh Foster · Director
  • Hen Suh Park · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Kelson Capital (CRD 149477) · New York, New YorkSold in NY

Signed by Anne-Marie Carbonell, President. Source: SEC Form D and 1 amendment, newest notice filed May 16, 2022. Read the notice at the SEC.

debt, optionsSEC
May 2019$3 MNo. 2$2 to $10 million

Oncosynergy, Inc.: Raise no. 2, May 2019

Investors in this round

6 investors had bought by the notice of Sep 8, 2020: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anne-Marie Suh Carbonell · Executive Officer, Director
  • Allen Salmasi · Director
  • Colin Suh Foster · Director
  • Hen Suh Park · Director
  • Robert Dunkle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anne-Marie Carbonell, President. Source: SEC Form D, newest notice filed Sep 8, 2020. Read the notice at the SEC.

equitySEC
Apr 2018$20 MNo. 1$10 to $50 million

Oncosynergy, Inc.: Raise no. 1, Apr 2018

Investors in this round

23 investors had bought by the notice of May 14, 2018: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $21 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anne-Marie Suh Carbonell · Executive Officer
  • W. Shawn Carbonell · Executive Officer, Director
  • Allen Shawn Salmasi · Director
  • Hen Suh Park · Director
  • Robert Shawn Dunkle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by W. Shawn Carbonell, President. Source: SEC Form D, newest notice filed May 14, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Oncosynergy, Inc. chose not to state its revenue in its newest notice of a funding round (May 2026).

    SEC Form D · May 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2026

That is all the official record says: Oncosynergy, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Oncosynergy, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 23 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Oncosynergy, Inc.
NameRoleNamed in
Anne-Marie Suh CarbonellExecutive officerMay 2026
W. Shawn CarbonellExecutive officerMay 2018
Allen SalmasiDirectorMay 2026
Anne-Marie Suh CarbonellDirectorMay 2026
Hen Suh ParkDirectorMay 2026
Colin Suh FosterDirectorMay 2022
Robert DunkleDirectorSep 2020
Allen Shawn SalmasiDirectorMay 2018
Robert Shawn DunkleDirectorMay 2018
W. Shawn CarbonellDirectorMay 2018